Price T Rowe Associates Inc Maravai Lifesciences Holdings, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 61,863 shares of MRVI stock, worth $485,005. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,863
Previous 73,595
15.94%
Holding current value
$485,005
Previous $639,000
30.67%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MRVI
# of Institutions
224Shares Held
125MCall Options Held
176KPut Options Held
2.2K-
12 West Capital Management LP New York, NY13.2MShares$104 Million9.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$84.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$76.3 Million0.0% of portfolio
-
Braidwell LP Stamford, CT9.02MShares$70.7 Million2.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$46.8 Million0.02% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $1.03B
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...